Med.Clin (Barc.) 4-5-2008;130(12):441-445
Goldstein, I., & Goldstein, S
A retrospective study conducted at the University Health Network found that, in liver transplant recipients with diabetes, combination therapy reduced HbA1c and alanine aminotransferase levels more effectively than DPP-4 inhibitors. Additionally, two clinical trials in patients with Type 2 diabetes demonstrated that combination therapy significantly lowered HbA1c by 1.34% and 1.21%, compared to a 0.54% reduction with placebo, starting from a baseline of 8.0%. These findings suggest that combination therapy may be especially beneficial in the liver transplant population, where patients often experience weight gain and develop metabolic co-morbidities
May your nutrient levels stay optimal, your energy stay consistent, and your GLP-1 journey stay well-supported.
Vitamin Shots Quick injections for an extra boost
More BAC water = lower concentration per unit drawn